Hypoglossal Nerve Stimulation for Sleep Apnea

Hypoglossal nerve stimulation, also called upper airway stimulation, is an implanted device therapy for obstructive sleep apnea. A small generator, placed under the skin of the upper chest during an outpatient procedure, connects to a sensing lead that detects breathing effort and a stimulation lead placed near the hypoglossal nerve, the nerve that controls tongue movement. During sleep, the device delivers mild, timed stimulation in coordination with inhalation, moving the tongue forward slightly to help keep the upper airway from collapsing.

CPAP is a mask-based therapy that mechanically holds the airway open with continuous air pressure, worn externally every night. Hypoglossal nerve stimulation is a surgically implanted device that works through nerve stimulation and muscle movement rather than air pressure, and it doesn't require a mask. The two therapies work through fundamentally different mechanisms, and hypoglossal nerve stimulation is generally considered for people for whom CPAP hasn't been a workable option, not as an interchangeable alternative for everyone.

Candidacy is determined individually, but in general terms, this therapy is considered for adults with moderate to severe obstructive sleep apnea who have been unable to tolerate or haven't had adequate success with CPAP. Additional factors that are typically evaluated include body weight and BMI, certain anatomic considerations, and the specific pattern of airway collapse identified on a pre-implant airway evaluation. These factors and their exact thresholds are assessed and can vary by device system and by individual clinical judgment, so a specific evaluation is the only way to know if someone qualifies.

Yes. A confirmed diagnosis of obstructive sleep apnea, typically from an in-lab sleep study, is a prerequisite for hypoglossal nerve stimulation. The sleep study establishes the diagnosis and severity, both of which factor directly into whether this therapy is an appropriate option.

Drug-induced sleep endoscopy is a brief outpatient procedure in which a patient is given sedating medication to simulate sleep while a physician uses a small camera to directly observe how the upper airway behaves and collapses. Many hypoglossal nerve stimulation programs use this procedure because certain patterns of airway collapse respond better to this therapy than others, and identifying that pattern beforehand helps confirm whether someone is a good candidate.

Implantation is an outpatient surgical procedure performed under anesthesia, generally involving one or more small incisions to place the device's generator and leads. Most patients go home the same day. As with any surgery, there are procedural risks and a recovery period to plan for, and your surgical team will walk through what to expect specific to your situation.

The device is typically not activated immediately. Most programs wait several weeks after implantation to allow the surgical sites to heal before turning the device on and beginning the programming process.

After activation, stimulation settings are adjusted by your clinician over a series of follow-up visits, gradually finding a level that's both effective at reducing airway collapse and comfortable to sleep with. This is a clinician-guided process, not something patients titrate on their own, though many devices let you turn nightly use on and off with a small handheld controller within the range your clinician sets.

Often, yes. Many programs schedule a follow-up sleep study after programming has stabilized to confirm the therapy is effectively reducing OSA severity, sometimes with settings adjusted during the study itself, conceptually similar to how a CPAP titration study fine-tunes pressure. This step confirms effectiveness rather than assuming it from symptom improvement alone.

For appropriately selected candidates, clinical studies have generally shown meaningful reductions in OSA severity and improvement in symptoms such as daytime sleepiness. Results vary between individuals, and it is not accurate to describe this therapy as a guaranteed cure or as working equally well for everyone. Your own expected response is best discussed with your treating physician based on your specific airway findings and health profile.

Yes. This is a therapy class, not a single product, and more than one manufacturer produces a hypoglossal nerve stimulation device with its own specific design, candidacy criteria, and programming approach. This page describes the therapy class broadly; a device-specific overview of one such system is covered separately for readers who want more detail on a particular device.

Coverage varies by insurer and plan, and typically requires documentation of a confirmed OSA diagnosis, a prior trial of CPAP that was not tolerated or effective, and results from the candidacy workup, including imaging or endoscopy findings where applicable. Our team can help review what documentation your specific plan requires before pursuing this therapy.